Business context and reporting period
DMY Technology Group, Inc. III filed this unaudited Form 10-Q for the quarter ended June 30, 2021. It was a shell SPAC, not IonQ’s operating-company financial statements; it had not commenced operations or generated revenue. In March 2021, DMY signed a merger agreement to combine with IonQ and entered PIPE subscription agreements for $350 million, subject to closing conditions.
Financial results and position
- Revenue: None. Operating margins are not meaningful for this pre-combination SPAC.
- Net loss: $7.93 million for Q2 and $9.96 million for the six months ended June 30. Q2 included $7.51 million of warrant-liability fair-value expense; the six-month expense was $5.72 million. Six-month general and administrative expense was $4.19 million.
- Cash flow: Six-month operating cash use was $1.69 million; $125,000 of related-party advances partly offset it. Cash at June 30 was $170.
- Assets and liquidity: Total assets were $300.80 million, principally $300.08 million held in the Trust Account. Current liabilities were $4.12 million and working capital deficiency was approximately $3.3 million. Trust funds were generally reserved for a business combination or shareholder redemptions.
- Liabilities and equity: Total liabilities were $55.22 million, including $40.60 million of derivative warrant liabilities, $10.50 million of deferred underwriting commissions, and $156,000 due to related parties. Stockholders’ equity was $5.00 million; $240.58 million of redeemable Class A shares was classified as temporary equity.
Material changes versus prior comparable period
The filing does not provide prior-year quarterly operating results for comparison. From December 31, 2020 to June 30, 2021, cash declined from $1.57 million to $170, warrant liabilities increased from $34.89 million to $40.60 million, and accrued expenses rose from $513,000 to $3.55 million. The number of Class A shares classified as subject to possible redemption decreased from 25.05 million to 24.06 million.
Outlook, risks, contingencies, and unusual items
- Management said available working capital and borrowing capacity would not be sufficient through the earlier of a business-combination closing or one year from filing, and disclosed substantial doubt about the company’s ability to continue as a going concern. It expected to rely on completing the combination; additional sponsor or insider loans were not committed.
- The SPAC’s deadline to complete a business combination was November 17, 2022; otherwise it must wind up and redeem public shares under the stated terms. The filing gives no operating-company guidance.
- Warrants are recorded as liabilities and remeasured at fair value, materially affecting reported losses. Management disclosed a material weakness in internal control related to warrant accounting and concluded disclosure controls were not effective, although it believed the financial statements were fairly presented.
- A note describes a lawsuit and counterclaims involving the company and sponsor in a broader dispute; the company denied the claims and said it intended to defend itself. The “Legal Proceedings” item separately states “None.” COVID-19 effects on closing the combination were described as uncertain. Management reported no other material changes to previously disclosed risk factors.
Important facts for investors to verify
- Whether the IonQ merger and $350 million PIPE closed, and the final transaction terms, redemption levels, and resulting dilution.
- How the going-concern liquidity shortfall was funded after June 30 and whether additional insider financing was committed.
- The status and potential exposure of the disclosed litigation, given the difference between the note disclosure and the “Legal Proceedings” item.
- Progress in remediating the warrant-accounting material weakness and the effect of warrant remeasurement on reported results.